PharmaCielo Ltd. PCLOF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.04M | -946.30K | 292.20K | -1.01M | -940.30K |
| Total Depreciation and Amortization | 74.60K | 627.70K | 314.30K | 61.80K | 209.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 851.10K | -2.43M | 164.30K | 861.00K | 732.10K |
| Change in Net Operating Assets | -51.30K | 25.70K | -390.10K | -2.48M | 1.53M |
| Cash from Operations | -164.60K | -2.72M | 380.70K | -2.56M | 1.53M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 26.00K | 2.45M | -540.40K | 5.38M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 26.00K | 2.45M | -540.40K | 5.38M | -- |
| Total Debt Issued | 240.00K | 115.00K | 150.00K | 25.00K | 125.00K |
| Total Debt Repaid | -- | 0.00 | 102.00K | -3.67M | -2.29M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 173.40K | 83.80K | 180.80K | -2.65M | -1.56M |
| Foreign Exchange rate Adjustments | 8.60K | -9.30K | 2.40K | 10.10K | -1.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 43.30K | -198.10K | 23.40K | 181.50K | -34.40K |